(51 of 54) remained free from the burden of continuous prophylaxis treatment through five years following a single infusion of HEMGENIX, demonstrating sustained therapeutic benefit- At year five, mean ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback